Faycal Guedj

Faycal Guedj

Auto-generated profile, based on publicly available information

Faycal Guedj

National Human Genome Research Institute, National Institutes of Health 1 Center for Precision Health Research, Prenatal Genomics and Therapy Section Bethesda, MD 20892

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
NANadine M. Aziz
Nadine M. Aziz
FGFaycal Guedj
Faycal Guedj
JPJeroen L. A. Pennings
Jeroen L. A. Pennings
JOJose Luis Olmos-Serrano
Jose Luis Olmos-Serrano
ASAshley Siegel
Ashley Siegel
DBDiana W Bianchi
Diana W Bianchi
Down syndrome (DS) results from triplication of human chromosome 21. Neuropathological hallmarks of DS include atypical central nervous system development that manifests prenatally and extends throughout life. As a result, individuals with DS exhibit cognitive and motor deficits and have delays in achieving developmental milestones. To determine whether different mouse models of DS recapitulate the human prenatal and postnatal phenotypes, here we directly compared brain histogenesis, gene expression, and behavior over the lifespan of three cytogenetically distinct mouse models of DS: Ts1Cje, Ts65Dn and Dp(16)1/Yey. Histological data indicated that Ts65Dn mice were the most consistently affected with respect to somatic growth, neurogenesis, and brain morphogenesis. Embryonic and adult gene expression results showed that Ts1Cje and Ts65Dn brains had considerably more differentially expressed (DEX) genes compared to Dp(16)1/Yey mice, despite the larger number of triplicated genes in the latter model. In addition, DEX genes showed little overlap in identity and chromosomal distribution in the three models, leading to dissimilarities in affected functional pathways. Perinatal and adult behavioral testing also highlighted differences among the models in their abilities to achieve various developmental milestones and perform hippocampal- and motor-based tasks. Interestingly, Dp(16)1/Yey mice showed no abnormalities in prenatal brain phenotypes, yet they manifested behavioral deficits starting at postnatal day 15 that continued through adulthood. In contrast, Ts1Cje mice showed mildly abnormal embryonic brain phenotypes, but only select behavioral deficits as neonates and adults. Altogether, our data showed widespread and unexpected fundamental differences in behavioral, gene expression, and brain development phenotypes between these three mouse models. Our findings illustrate unique limitations of each model when studying aspects of brain development and function in DS. This work helps to inform model selection in future studies investigating how observed neurodevelopmental abnormalities arise, how they contribute to cognitive impairment, and when testing therapeutic molecules to ameliorate the intellectual disability associated with DS.

1 November 2020 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
FGFaycal Guedj
Faycal Guedj
ASAshley E. Siegel
Ashley E. Siegel
JPJeroen L.A. Pennings
Jeroen L.A. Pennings
FAFatimah Alsebaa
Fatimah Alsebaa
LMLauren J. Massingham
Lauren J. Massingham
DBDiana W Bianchi
Diana W Bianchi

1 February 2020 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
SLSarah E. Lee
Sarah E. Lee
MDMonica Duran-Martinez
Monica Duran-Martinez
SKSabina Khantsis
Sabina Khantsis
DBDiana W Bianchi
Diana W Bianchi
FGFaycal Guedj
Faycal Guedj

5 January 2023 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
ASAshley Emily Siegel
Ashley Emily Siegel
DBDiana W Bianchi
Diana W Bianchi
FGFaycal Guedj
Faycal Guedj

26 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FGFaycal Guedj
Faycal Guedj
EKElise Kane
Elise Kane
LBLauren A. Bishop
Lauren A. Bishop
JPJeroen L. A. Pennings
Jeroen L. A. Pennings
YHYann Herault
Yann Herault
DBDiana W Bianchi
Diana W Bianchi
Despite many successful preclinical treatment studies to improve neurocognition in the Ts65Dn mouse model of Down syndrome (DS), translation to humans has failed. This raises critical questions about the appropriateness of the Ts65Dn mouse as the “gold standard” for DS research given that it carries, in addition to Mmu16 orthologous genes, triplication of 50 Mmu 17 non-orthologous genes that might contribute to the observed brain and behavioral phenotypes. We used the novel Ts66Yah mouse that carries both an extra mini chromosome and the identical segmental Mmu16 trisomy as Ts65Dn, but in which the Mmu17 non-orthologous region was removed using CRISPR/Cas9 technology. We demonstrate that the Ts65Dn exhibits a more severe phenotype throughout the lifespan compared to the Ts66Yah mouse. Several Mmu17 non-orthologous genes were uniquely overexpressed in Ts65Dn embryonic forebrain; this produced major differences in dysregulated genes and pathways. Despite these genome-wide differences, the primary Mmu16 trisomic effects were highly conserved in both models, resulting in several commonly dysregulated disomic genes and pathways. During the neonatal period, delays in motor development, communication and olfactory spatial memory were observed in both Ts66Yah and Ts65Dn pups but were more pronounced in Ts65Dn. Adult Ts66Yah mice showed working memory deficits and sex-specific effects in exploratory behavior and spatial hippocampal memory, while long-term memory was preserved. Like the neonates, adult Ts66Yah mice exhibited fewer and milder behavioral deficits when compared to Ts65Dn mice. Our findings suggest that trisomy of the non-orthologous Mmu 17 genes significantly contributes to the phenotype of the Ts65Dn mouse and may be one major reason why preclinical trials that used this model have unsuccessfully translated to human therapies.

22 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAshley Siegel
Ashley Siegel
DBDiana W Bianchi
Diana W Bianchi
FGFaycal Guedj
Faycal Guedj
Humans with Down syndrome (DS) exhibit hippocampal learning deficits in the Cambridge Neuropsychological Test Automated Battery (CANTAB). Here we translated the CANTAB Visual Discrimination (VD) and Extinction tasks to investigate hippocampal learning and cortical inhibitory control in the Dp(16)1/Yey, Ts65Dn and Ts1Cje mouse models of DS. No food or water restriction was used prior to testing. The number of days to reach 70% correct answers and percent of correct responses were analyzed. All Dp(16)1/Yey, Ts1Cje and WT mice reached Stage 5 of pre-training. No differences between genotypes were found in percent of correct responses. Five Ts65Dn and one WT animals reached Stage 5 and only one Ts65Dn mouse reached VD. Ts1Cje mice took longer (17.86±3.19 days) to move to VD vs. WT (11.44±1.96 days, P =0.09). There were no differences between Dp(16)1/Yey and WT mice. At VD, the average percent of correct answers was significantly lower in Dp(16)1/Yey (22.70±1.93%) and Ts1Cje (34.39±1.98%) compared to WT littermates (32.18±1.49% and 41.11±1.45%, respectively, P <0.05). In another set of experiments, we demonstrated that mild food restriction significantly reduced the time needed to complete pre-training in C57BL/6J mice compared to C67BL/6J mice that had ad libitum access to food and water. In conclusion, we were able to apply human cognitive tests to evaluate hippocampal learning and cortical inhibitory control in three mouse models of DS. These studies demonstrate significant cognitive differences between strains. Future experiments will evaluate whether food restriction and/or pre- and postnatal therapy decreases the time intervals to achieve training mile.